Insys Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Insys Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 42% to $82,080,000. The net income raised on -$124,507,000 and profit margin reached -152%. Total operating expenses were $199,000,000.
Profit Margin
| 2013 | 99.28M | 40.37M | 40.67% |
|---|---|---|---|
| 2014 | 222.12M | 37.97M | 17.1% |
| 2015 | 330.79M | 58.47M | 17.68% |
| 2016 | 242.27M | 7.59M | 3.13% |
| 2017 | 140.69M | -228.01M | -162.07% |
| 2018 | 82.08M | -124.50M | -151.69% |
INSY Income Statement (2013 – 2018)
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 82.08M | 140.69M | 242.27M | 330.79M | 222.12M | 99.28M |
Cost of revenue | 10.80M | 20.64M | 25.39M | 28.85M | 22.57M | 12.66M |
Gross profit | 71.27M | 120.05M | 216.88M | 301.94M | 199.54M | 86.62M |
Operating exp. | ||||||
Research and development | 57.57M | 62.95M | 73.91M | 55.28M | 33.13M | 8.49M |
Selling and marketing | 31.37M | 48.87M | 69.65M | 80.66M | 58.10M | 29.19M |
Total operating expenses | 199M | 339.08M | 209.55M | 209.51M | 135.52M | 54.06M |
Operating income | -127.72M | -219.03M | 7.32M | 92.43M | 64.02M | 32.55M |
Other income (expenses), net | 1.31M | 1.83M | 1.09M | 538K | 153K | -982K |
Income before tax | -126.40M | -217.19M | 8.42M | 92.96M | 64.17M | 31.57M |
Income tax expense | -1.9M | 10.82M | 834K | 34.49M | 26.19M | -8.8M |
Net income | -124.50M | -228.01M | 7.59M | 58.47M | 37.97M | 40.37M |
Earnings per share | ||||||
Basic EPS | -1.68 | -3.16 | 0.11 | 0.82 | 1.1 | 2.34 |
Diluted EPS | -1.68 | -3.16 | 0.1 | 0.77 | 1.04 | 2.11 |
| Data source | Data source | Data source | Data source | Data source | Data source |